ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

March 16, 1979

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

NCI Advisory Group Meetings for September

August 29, 1975

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004

NCAB Approves Concept Of Four Contract Program

May 29, 1981

Solomon Gard’s Questions/Answers

January 2, 1981